Agilent Technologies, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Agilent Technologies, Inc.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
Swedish biotech Amniotics is developing a broad pipeline of unique stem cell therapeutics based on technology that is broadly applicable to major disease markets which should eventually draw the attention of big pharma players, its CEO tells Scrip.
Dealmaking Quarterly Statistics, Q1 2021: Boston Scientific, Roche Start The Year With Billion-Dollar-Plus Acquisitions
During the first quarter, medical device company mergers and acquisition totalled $10.2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $5bn.
Plus deals involving AbbVie/Mitokinin, Roivant/Silicon Therapeutics, CASI/Cleave Therapeutics, Tallac/ALX Oncology, AgeX/LyGenesis, Chinook/Evotec and more.
- Contract Research Organization-CRO
- In Vitro Diagnostics
- Laboratory Testing Services
- Research, Analytical Equipment & Supplies
- Chiral Chemistry
- Diagnostic Equipment & Supplies
- Synthesis Technologies, Production Processes
- Other Names / Subsidiaries
- ACEA Biosciences
- Advanced Analytical Technologies
- J&W Scientific Inc.
- Lasergen, Inc.
- Luxcel Biosciences
- Resolution Bioscience, Inc.
- Seahorse Bioscience
- Silicon Genetics
- Ultra Scientific